Sensitizing tumor response to cancer therapy

July 28, 2009

By Flinn Foundation

[Source: Susan McGinley, University of Arizona] – Tow forms of skin and brain cancer respond very poorly to chemotherapy and radiation: melanoma and glioblastoma multiforme brain cancer.

Both are the focus of an intensive effort in the department of nutritional sciences at The University of Arizona to find natural, biologically active compounds that will sensitize the cancerous tumors to therapy without damaging normal tissue. By using the compounds in conjunction with conventional treatment, the researchers hope patient survival rates will ultimately increase. 

For more information:   Sensitizing Tumor Response to Cancer Therapy